These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8714521

  • 1. Dopamine differentiation factors increase striatal dopaminergic function in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mice.
    Jin BK, Iacovitti L.
    J Neurosci Res; 1996 Feb 01; 43(3):331-4. PubMed ID: 8714521
    [Abstract] [Full Text] [Related]

  • 2. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y, Watanabe A, Mori A, Koga N.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):660-3. PubMed ID: 9703982
    [Abstract] [Full Text] [Related]

  • 3. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N, Bourque M, Al Sweidi S, Morissette M, Di Paolo T.
    Neuropharmacology; 2015 Oct 30; 97():86-94. PubMed ID: 26006269
    [Abstract] [Full Text] [Related]

  • 4. Dopamine differentiation factors produce partial motor recovery in 6-hydroxydopamine lesioned rats.
    Jin BK, Iacovitti L.
    Neurobiol Dis; 1995 Feb 30; 2(1):1-12. PubMed ID: 8980004
    [Abstract] [Full Text] [Related]

  • 5. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 30; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 6. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY, Albers DS, Sonsalla PK.
    Brain Res; 1998 Apr 20; 790(1-2):264-9. PubMed ID: 9593931
    [Abstract] [Full Text] [Related]

  • 7. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
    Shepherd KR, Lee ES, Schmued L, Jiao Y, Ali SF, Oriaku ET, Lamango NS, Soliman KF, Charlton CG.
    Pharmacol Biochem Behav; 2006 Mar 20; 83(3):349-59. PubMed ID: 16580056
    [Abstract] [Full Text] [Related]

  • 8. Increased striatal dopamine turnover following acute administration of rotenone to mice.
    Thiffault C, Langston JW, Di Monte DA.
    Brain Res; 2000 Dec 08; 885(2):283-8. PubMed ID: 11102582
    [Abstract] [Full Text] [Related]

  • 9. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
    Kozina EA, Khakimova GR, Khaindrava VG, Kucheryanu VG, Vorobyeva NE, Krasnov AN, Georgieva SG, Kerkerian-Le Goff L, Ugrumov MV.
    J Neurol Sci; 2014 May 15; 340(1-2):198-207. PubMed ID: 24768159
    [Abstract] [Full Text] [Related]

  • 10. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF).
    Date I, Notter MF, Felten SY, Felten DL.
    Brain Res; 1990 Aug 27; 526(1):156-60. PubMed ID: 1706636
    [Abstract] [Full Text] [Related]

  • 11. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ, Hebert G, Lin LY, Luo YL, Moze E, Li KS, Neveu PJ.
    J Neuroimmunol; 2005 Jan 27; 158(1-2):14-25. PubMed ID: 15589033
    [Abstract] [Full Text] [Related]

  • 12. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Kozina EA, Kim AR, Kurina AY, Ugrumov MV.
    Neurobiol Dis; 2017 Feb 27; 98():108-121. PubMed ID: 27940203
    [Abstract] [Full Text] [Related]

  • 13. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan 27; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Hadjiconstantinou M, Fitkin JG, Dalia A, Neff NH.
    J Neurochem; 1991 Aug 27; 57(2):479-82. PubMed ID: 1677029
    [Abstract] [Full Text] [Related]

  • 15. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
    Dluzen DE.
    Brain Res; 1996 Apr 09; 715(1-2):113-8. PubMed ID: 8739629
    [Abstract] [Full Text] [Related]

  • 16. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
    Ookubo M, Yokoyama H, Kato H, Araki T.
    Mol Cell Endocrinol; 2009 Nov 13; 311(1-2):62-8. PubMed ID: 19631714
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice.
    Otto D, Unsicker K.
    J Neurosci; 1990 Jun 13; 10(6):1912-21. PubMed ID: 1972393
    [Abstract] [Full Text] [Related]

  • 19. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar 13; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.